Advertisement Harvard Bioscience names new CFO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Harvard Bioscience names new CFO

Harvard Bioscience, a developer, manufacturer, and marketer of a broad range of tools to advance life science research, has appointed Thomas McNaughton as its new CFO.

Mr McNaughton most recently served as CFO for Tivoli Audio, a venture capital-backed global manufacturer of audio systems. Prior to joining Tivoli, Mr McNaughton spent 14 years at Cabot where he held the position of CFO of Cabot Supermetals.

Prior to serving as CFO of this division, Mr McNaughton held various finance positions of increasing responsibility including financial reporting, treasury, investor relations and acquisitions within Cabot.

Chane Graziano, CEO of Harvard Bioscience, said: “We are very pleased to have Tom join our team. Tom’s background and experience are a perfect fit for Harvard Bioscience and will provide great value that will assist us in achieving our long-term growth objectives.”